Company: ARWR
Filing Date: 2025-03-07
Form Type: 424B7
Source: 0001193125-25-049889
Chunk: 28

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-03-07
Form: 424B7
Chunk 28
---
 we will file with the SEC in connection with any offering of warrants. Debt Warrants The prospectus supplement relating to a particular issue of warrants exercisable for debt securities will describe the terms of those warrants, including the following:

| • |     | the title of the warrants; |

| • |     | the offering price for the warrants, if any; |

| • |     | the aggregate number of the warrants; |

| • |     | the designation and terms of the debt securities purchasable upon exercise of the warrants; |

| • |     | if applicable, the designation and terms of the securities that the warrants are issued with and the number of 
 warrants issued with each security;                                                                            |

| • |     | if applicable, the date from and after which the warrants and any securities issued with the warrants will be 
 separately transferable;                                                                                      |

| • |     | the principal amount and price of debt securities that may be purchased upon exercise of a warrant; |

| • |     | the dates on which the right to exercise the warrants commences and expires; |

| • |     | if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; |

| • |     | whether the warrants represented by the warrant certificates or debt securities that may be issued upon exercise 
 of the warrants will be issued in registered or bearer form;                                                     |

| • |     | information relating to book-entry procedures, if any; |

| • |     | if applicable, a discussion of material U.S. federal income tax considerations; |

| • |     | anti-dilution provisions of the warrants, if any; |

| • |     | redemption or call provisions, if any, applicable to the warrants; and |

| • |     | any additional terms of the warrants, including terms, procedures and limitations relating to the exchange and 
 exercise of the warrants.                                                                                      |

Stock Warrants The prospectus supplement relating to a particular issue of warrants exercisable for common stock or preferred stock will describe the terms of the common stock warrants and preferred stock warrants, including the following:

| • |     | the title of the warrants; |

14

| • |     | the offering price for the warrants, if any; |

| • |     | the aggregate number of the warrants; |

| • |     | the designation and terms of the common stock or preferred stock that may be purchased upon exercise of the 
 warrants;                                                                                                   |

| • |     | if applicable,